FHCCX vs. FBTTX
Compare and contrast key facts about Fidelity Advisor Health Care Fund Class C (FHCCX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX).
FHCCX is managed by Fidelity. It was launched on Nov 3, 1997. FBTTX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
FHCCX vs. FBTTX - Performance Comparison
Loading graphics...
FHCCX vs. FBTTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FHCCX Fidelity Advisor Health Care Fund Class C | -9.80% | -5.49% | 3.20% | 3.02% | -13.72% | 10.43% | 20.15% | 26.96% | 6.37% | 23.12% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | -2.77% | 39.21% | 5.08% | 10.43% | -8.22% | -3.35% | 31.82% | 25.39% | -4.19% | 25.37% |
Returns By Period
In the year-to-date period, FHCCX achieves a -9.80% return, which is significantly lower than FBTTX's -2.77% return. Over the past 10 years, FHCCX has underperformed FBTTX with an annualized return of 5.57%, while FBTTX has yielded a comparatively higher 10.99% annualized return.
FHCCX
- 1D
- -0.72%
- 1M
- -9.58%
- YTD
- -9.80%
- 6M
- -16.82%
- 1Y
- -13.69%
- 3Y*
- -3.33%
- 5Y*
- -3.13%
- 10Y*
- 5.57%
FBTTX
- 1D
- -0.78%
- 1M
- -6.09%
- YTD
- -2.77%
- 6M
- 11.26%
- 1Y
- 42.32%
- 3Y*
- 18.16%
- 5Y*
- 7.66%
- 10Y*
- 10.99%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FHCCX vs. FBTTX - Expense Ratio Comparison
FHCCX has a 1.72% expense ratio, which is higher than FBTTX's 1.28% expense ratio.
Return for Risk
FHCCX vs. FBTTX — Risk / Return Rank
FHCCX
FBTTX
FHCCX vs. FBTTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Health Care Fund Class C (FHCCX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FHCCX | FBTTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.56 | 1.55 | -2.11 |
Sortino ratioReturn per unit of downside risk | -0.55 | 2.09 | -2.64 |
Omega ratioGain probability vs. loss probability | 0.90 | 1.27 | -0.36 |
Calmar ratioReturn relative to maximum drawdown | -0.55 | 2.36 | -2.90 |
Martin ratioReturn relative to average drawdown | -1.35 | 9.47 | -10.82 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FHCCX | FBTTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.56 | 1.55 | -2.11 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.16 | 0.33 | -0.49 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.29 | 0.45 | -0.16 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.45 | 0.29 | +0.16 |
Correlation
The correlation between FHCCX and FBTTX is 0.83, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FHCCX vs. FBTTX - Dividend Comparison
FHCCX has not paid dividends to shareholders, while FBTTX's dividend yield for the trailing twelve months is around 1.58%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FHCCX Fidelity Advisor Health Care Fund Class C | 0.00% | 0.00% | 17.59% | 0.00% | 0.00% | 8.32% | 6.85% | 0.41% | 6.43% | 0.00% | 0.00% | 7.84% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | 1.58% | 1.53% | 6.41% | 0.93% | 0.00% | 21.60% | 8.79% | 7.10% | 2.64% | 0.00% | 0.00% | 5.42% |
Drawdowns
FHCCX vs. FBTTX - Drawdown Comparison
The maximum FHCCX drawdown since its inception was -45.28%, smaller than the maximum FBTTX drawdown of -63.75%. Use the drawdown chart below to compare losses from any high point for FHCCX and FBTTX.
Loading graphics...
Drawdown Indicators
| FHCCX | FBTTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.28% | -63.75% | +18.47% |
Max Drawdown (1Y)Largest decline over 1 year | -27.25% | -13.58% | -13.67% |
Max Drawdown (5Y)Largest decline over 5 years | -29.67% | -36.64% | +6.97% |
Max Drawdown (10Y)Largest decline over 10 years | -29.67% | -39.04% | +9.37% |
Current DrawdownCurrent decline from peak | -27.25% | -7.33% | -19.92% |
Average DrawdownAverage peak-to-trough decline | -10.12% | -21.96% | +11.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.08% | 4.13% | +6.95% |
Volatility
FHCCX vs. FBTTX - Volatility Comparison
The current volatility for Fidelity Advisor Health Care Fund Class C (FHCCX) is 5.59%, while Fidelity Advisor Biotechnology Fund Class M (FBTTX) has a volatility of 7.77%. This indicates that FHCCX experiences smaller price fluctuations and is considered to be less risky than FBTTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FHCCX | FBTTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.59% | 7.77% | -2.18% |
Volatility (6M)Calculated over the trailing 6-month period | 22.17% | 16.36% | +5.81% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.40% | 25.56% | -0.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.34% | 23.23% | -3.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.55% | 24.55% | -5.00% |